Impact of serum tumor marker determination on the management of women with borderline ovarian tumors: multivariate analysis of a French multicentre study.
Fiche publication
Date publication
novembre 2010
Journal
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr COUTANT Charles
Tous les auteurs :
Poncelet C, Fauvet R, Yazbeck C, Coutant C, Darai E
Lien Pubmed
Résumé
To evaluate the contribution of preoperative serum tumor markers to manage borderline ovarian tumors (BOT).
Mots clés
Adult, Aged, Analysis of Variance, Ascites, etiology, Biomarkers, Tumor, blood, CA-125 Antigen, blood, CA-19-9 Antigen, blood, Carcinoembryonic Antigen, blood, Female, Follow-Up Studies, France, Frozen Sections, Humans, Laparoscopy, Laparotomy, Logistic Models, Middle Aged, Mucin-1, blood, Neoplasm Staging, Ovarian Neoplasms, blood, Radioimmunoassay, Retrospective Studies, Severity of Illness Index
Référence
Eur J Surg Oncol. 2010 Nov;36(11):1066-72